Locations:
Search
Despite several high profile failures, Alzheimer’s drug development continues with a diverse pipeline beyond amyloid
Spectacular Night of Philanthropy to Benefit Cleveland Clinic Lou Ruvo Center for Brain Health
New imaging study is the first to use GE180 in this patient population to better understand the role of inflammation in disease pathology
Jobs, Construction, Spending and Taxes Add Up to Sizable Addition to State, Local Economies
However, new trends include emphasis on disease-modifying therapies and an increased use of biomarkers
Distinguished clinician, researcher and author brings more than 27 years of expertise in Alzheimer’s disease to lead one of the largest memory disorders group in the country
Figure includes outreach programs, medical education, research, subsidized care
Assessment reveals desperately slow period in drug development, with only eight new agents entering Phase I since 2016
Star-studded lineup continues to grow as celebrity chef Michael Mina joins Wolfgang Puck in the kitchen at the annual event benefitting Cleveland Clinic Lou Ruvo Center for Brain Health
Classes for the post-professional degree program begins Aug. 29